You are here: Industry Insights > NIHR

News List

Problems in thinking and attention linked to COVID-19 infection worldpharmanews
August 13, 2021
The research found that those with more severe COVID-19 symptoms scored lower on an online series of tests, with performance on reasoning and problem-solving tasks being most affected.
‘Mix and match’ COVID-19 vaccine study yields promising results pharmatimes
June 30, 2021
A study evaluating a mix and match approach to COVID-19 vaccinations has found that using a different jab for the first and second doses gives good protection against the virus.
Protein identified as new therapeutic anti-viral target for COVID-19 worldpharmanews
June 10, 2021
New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new therapeutic anti-viral target.
New research identifies single biomarker that can indicate underlying neurodegeneration pharmatimes
June 09, 2021
New research has identified a single biomarker that can be used to accurately identify underlying neurodegeneration among people with cognitive issues.
UK government pledges £18.5m for long COVID research pharmatimes
February 19, 2021
The UK government has announced it will provide £18.5m to fund research projects aimed at improving understanding of the causes and effects of the longer term effects of COVID-19 – known as long COVID.
Oxford University launches Covid-19 vaccine study in children pharmaceutical-technology
February 18, 2021
The University of Oxford has launched the first study of ChAdOx1 nCoV-19 Covid-19 vaccine in children and young adults.
UK trial will evaluate safety of mixing different COVID-19 vaccines pharmatimes
February 04, 2021
A new clinical study, based in the UK, will investigate alternating COVID-19 vaccine doses with the aim of examining whether different vaccines can safely be used for two-dose regimens.
NIHR establishes new patient recruitment research centres pharmatimes
November 16, 2020
The National Institute for Health Research (NIHR) has launched five national patient recruitment centres (NPRCs) to accelerate and aid life sciences companies to deliver late-stage clinical research within the NHS.
New study assessing antibiotics for COVID-19 sepsis pharmatimes
November 04, 2020
Researchers from an NIHR-funded study are looking at how to improve the use of antibiotics for patients with COVID-19 who are at risk of developing sepsis and thus organ failure and death.
Asthma fund launched to support development and adoption of new technologies pharmatimes
October 22, 2020
A new fund aiming to support the development and adoption of technology for people with asthma has been created by Asthma UK and the British Lung Foundation alongside the National Institute for Health Research (NIHR) and the Engineering and ...

Previous page 1 2 3 4 Next page